Atomo Diagnostics Limited (ASX:AT1)
Australia
· Delayed Price · Currency is AUD 0.0390
+0.0010 (2.63%)
At close: Mar 5, 2026
Atomo Diagnostics Company Description
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide.
The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand.
It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Atomo Diagnostics Limited
| Country | Australia |
| Founded | 2010 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 85 |
| CEO | John Kelly |
Contact Details
Address: 3-5 George Street Leichhardt, NSW 2040 Australia | |
| Phone | 61 2 9099 4750 |
| Website | atomodiagnostics.com |
Stock Details
| Ticker Symbol | AT1 |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000080327 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| John Michael Kelly | Founder, Chief Executive Officer and MD |
| Chandra Sukumar | Chief Operating Officer |
| Suzy Elhlou | Finance Manager |
| Mathew Leslie Watkins C.A. | Company Secretary |